Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from the pharmaceutical segment for a live panel discussion on 11 June 2021. Amid the onslaught of the second wave of COVID-19, the healthcare sector in India is under heavy pressure owing to the rising cases across different states. Moreover, the growing demand for medicines, protective gears and other pharmaceutical equipment has given rise to counterfeiting, tampering
The post ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain appeared first on Pharma Mirror Magazine.
